期刊文献+

多囊卵巢综合征患者IVF-ET前达英-35预处理不同时间临床效果分析 被引量:8

A Clinical Analysis on the Effective of Diane-35 Pretreatment for 1-6 months for Patients with PCOS in IVF
原文传递
导出
摘要 目的:探讨不同的达英-35预处理时间对多囊卵巢综合征患者IVF-ET助孕结局的影响。方法:回顾性分析在我院接受IVF助孕的119个PCOS助孕周期。所有患者均接受达英-35预处理,根据达英-35预处理周期数分为A组(达英-35预处理时间≤3个月),B组(达英-35预处理时间>3个月),检测比较治疗前、后血清LH水平、睾酮水平、游离雄激素指数(FAI)、获卵数、空卵泡率、临床妊娠率、着床率、OHSS发生率等。结果:A、B组达英-35预处理前血清LH值分别为:5.96±3.03 IU/L、6.91±4.40 IU/L;FAI分别为:1.42±1.10、1.76±1.67,治疗后均明显下降,与治疗前比有显著统计学差异(LH:3.50±2.19 IU/L,3.78±0.21 IU/L,FAI:0.54±0.38,0.54±0.48,P<0.05);B组空卵泡率、OHSS发生率分别为17.4%、6.8%,均低于A组(30.2%,20.0%),受精率为83.5%,较A组(74.8%)高,差异均有统计学意义(P<0.05)。结论:IVF前达英-35预处理可以显著降低PCOS患者高LH、高雄激素水平;随着达英-35预处理时间延长,空卵泡率和OHSS发生率进一步下降,受精率得到改善。 Objective: To explore the effect of Diane-35 pretreatment for patients with PCOS in IVF.Methods: A retrospective analysis was performed on 119 IVF cycles of patients with PCOS.The cycles were classified into two groups by the pretreatment time of Diane-35: group A(n=60 cycles) took with Diane-35 for 1-3 months,group B(n=59 cycles) took with Diane-35 for more than 3 months.The serum LH level,free androgen index(FAI),pregnancy rate and OHSS rate were compared between the two groups.Results: The level of serum LH and FAI were much lower in two groups after Diane-35 pretreatment than that before Diane-35 pretreatment (group A: 3.50±2.19 IU/L vs 5.96±3.03 IU/L,0.54±0.38 vs 1.42±1.10;group B: 3.78±0.21 IU/L vs 6.91±4.40 IU/L,0.54±0.48 vs 1.76±1.67).The incidence of OHSS and empty follical in group A(6.8%,17.4%) were higher than those in group B(20.0%,30.2%,P=0.05).Pregnancy rate was not different between the two groups (83.5% vs 74.8% P0.05).Conclusion: The serum LH level and FAI were suppressed by Diane-35 and the incidence of OHSS and empty follical will be much lower if the time of Diane-35 pretreatment be much longer.
出处 《生殖与避孕》 CAS CSCD 北大核心 2010年第10期710-712,717,共4页 Reproduction and Contraception
关键词 IVF-ET PCOS 卵巢过度刺激综合征(OHSS) 空卵泡率 达英-35 IVF-ET polycystic ovarian syndrome(PCOS) OHSS empty follical
  • 相关文献

参考文献8

二级参考文献56

共引文献386

同被引文献96

  • 1杨海燕,叶碧绿,赵军招,林金菊,林文琴,池海虹.二甲双胍联合复方醋酸环丙孕酮预治疗对多囊卵巢综合征不育患者促排卵疗效的影响[J].生殖医学杂志,2005,14(6):325-328. 被引量:11
  • 2Ashkenazi J, Farhi J, Orvieto R, et al. Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient[J]. Fertil Steril, 1995, 64 (3): 564-7.
  • 3Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation[J]. Fertil Steril, 2002, 77(6): 1170-7.
  • 4Orvieto R, Meltcer S, Liberty G, et al. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue [J]? Gynecol Endocrinol, 2012, 28(6): 422-4.
  • 5Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81 (1): 19-25.
  • 6Regan L, Owen [J, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage [J]. Lancet, 1990, 336(8724): 1141-4.
  • 7Balen AH, Tan SL, Jacobs HS. Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage [J]. Br J Obstet Gynaecol, 1993, 100(12): 1082-9.
  • 8Balen AH, Tan SL, Macdougall J, et al. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin [J]. Hum Reprod, 1993, 8(6): 959-64.
  • 9Homburg R, Levy T, Berkovitz D, et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome [J]. Fertil Steril. 1993.59(3): 527-31.
  • 10Damario MA, Barmat L, Liu HC, et al. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients [J]. Hum Reprod, 1997, 12(11): 2359-2365.

引证文献8

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部